Fully Funded PhD Scholarships at Manchester Metropolitan University, UK 2022-23

This is to bring to your notice that the application window for the Fully Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23 is now open for interested and qualified applicants.

Important Points 

Listed below are the summarized points you need to note about the Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23: 

• Funding is full 
• They take Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University
• Domestic students are eligible
• All PhD students are eligible

Brief Description

Remove the financial barriers that are impeding your education. Apply for PhD Scholarships at Manchester Metropolitan University in Investing Pim Kinase, A Novel Anti-Thrombotic Endothelium Targeting Strategy to help fund your education in the UK.

The goal of this research is to figure out how Pim kinase, a novel antithrombotic target, regulates endothelial cell activity and to see if Pim kinase inhibitors can preserve endothelial cells’ anti-inflammatory and antithrombotic qualities.

Application Deadline

Application deadline is ongoing. 

Eligible Courses

The Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23, is a scheme that looks to reward high-achieving internationals, and it is only available for the course below:

• Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy 

Eligible Countries 

Students from the following nationalities are eligible:

• UK

Scholarship Award Benefit

All of the following will be provided by the university:

• The goal of this research is to figure out how Pim kinase, a novel antithrombotic target, regulates endothelial cell activity and to see if Pim kinase inhibitors can preserve endothelial cells’ anti-inflammatory and antithrombotic qualities.

Degree Type 

Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23 is primarily for PhD programs.

Number of Awards

Not specified 

Eligibility Criteria

All applicants must meet the following criteria to be considered for the Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23:

• Remove the financial barriers that are impeding your education. Apply for PhD Scholarships at Manchester Metropolitan University in Investing Pim Kinase, A Novel Anti-Thrombotic Endothelium Targeting Strategy to help fund your education in the UK.

Application Procedure

To apply, all arranged and organized steps have been highlighted below for the Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23:

• For a casual chat, interested applicants may contact Dr. Amanda Unsworth. To apply, please fill out the PhD Biological Sciences Full-Time online application form (or download the PGR application form). You should also fill out the PGR thesis proposal (supplementary information) form, which addresses the project’s goals and objectives, indicating how your talents translate to the study topic, and why you think this subject is important and interesting.
• Important Papers: Students must send the application form and statement to PGRAdmissions@mmu.ac.uk or upload it in the supporting papers area.
• Applicants must have or anticipate to achieve an Upper Second Class Honours Degree in Biomedical Sciences, Biochemistry, Biology, or similar comparable topic.
• Language Prerequisite: You must be able to communicate in English.

Please click the Fully-Funded PhD Scholarships in Investing Pim Kinase, A Novel Antithrombotic Endothelium Targeting Strategy at Manchester Metropolitan University, UK 2022-23, to begin your application.

Not interested in this particular scholarship? See other scholarships here